Advanced wound dressings with Hydrofiber technology
ConvaTec, a world-leading developer and marketer of innovative medical technologies for community and hospital care, announced the launch of AQUACEL Ag SURGICAL cover dressings, now available in the U.S., for the post-operative care of surgical incisions.
Featuring the ConvaTec patented Hydrofiber Technology combined with skin-friendly hydrocolloid technology, AQUACEL Ag SURGICAL cover dressings are supported by evidence showing significant reduction in the incidence of superficial surgical site infection (SSI), skin blistering and delayed discharge as compared to a non-woven post-operative surgical cover dressing regimen.(1a), (2b) The unique construction of AQUACEL Ag SURGICAL cover dressings provides a waterproof, viral and bacterial barrier* that allows for flexibility and extensibility during body movement.
"The innovative design of AQUACEL Ag SURGICAL cover dressings has been proven to handle post-operative challenges – complications that can translate to increased time, expense and concern for the patient's well-being," said Michael Steadman, President of ConvaTec Wound Therapeutics. "Clinicians caring for patients with acute and chronic wounds from all over the world are familiar with the benefits of Hydrofiber Technology, which we are now pleased to make available to the surgical community in an easy-to-use solution for their post-operative needs."
The performance of AQUACEL Ag SURGICAL cover dressings is powered by unique gelling action of the ConvaTec advanced Hydrofiber Technology dressings, which absorb and lock in fluid, including harmful bacteria.(3c)
In a prospective study, involving 428 patients undergoing hip or knee surgery, a hospital's then standard non-woven post-operative dressing regimen (Mepore dressing covering AQUACEL dressing) was compared with a new dressing regimen of AQUACEL dressing covered with DuoDERM Extra Thin dressing (the main components of AQUACEL SURGICAL cover dressing) after application of a liquid film-forming acrylate. The new dressing regimen demonstrated a reduction in superficial surgical site infection of 67 percent (p<0.03), a="" reduction="" in="" blistering="" of="" 88="" percent="">0.03),><0.001) and="" a="" reduction="" in="" delayed="" discharge="" of="" 80="" percent="">0.001)><0.02).(1a), (2b)="">0.02).(1a),>
Advanced Wound Dressings with Hydrofiber Technology from ConvaTec
ConvaTec dressings with Hydrofiber Technology gel on contact with fluid, providing clinicians and patients with substantial wound care benefits. This unique gelling action enables the dressings to lock in exudate and its harmful components(3,6,7c) and contour closely to the wound bed,(8c) in response to changing wound conditions. With the addition of ionic silver, AQUACEL Ag dressing also provides "on demand" broad-spectrum antimicrobial activity.(4,9c,d)
For incisions that are infected or at risk of infection, AQUACEL Ag dressing provides rapid and sustained antimicrobial activity, killing a broad spectrum of pathogens, including methicillin-resistant Staphylococcus aureus (MRSA) and vancomycin-resistant enterococci (VRE), within 30 minutes of exposure to the dressing,(4) for up to 7 days,(5) as demonstrated in a simulated wound model in vitro.
AQUACEL Ag dressings are soft, absorbent non-woven wound dressings based on Hydrofiber Technology.